About Sheila Gujrathi
Form D filings for Lila Biologics in 2023 list Sheila Gujrathi as director.
Sheila Gujrathi first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Sheila Gujrathi in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sheila Gujrathi works with at each company, as listed on that company's latest Form D.
Lila Biologics, Inc. · Form D, Sep 28, 2023
WC
William Canestaro
Director
JI
John Kraft, II
Chief Executive Officer and director
AR
Anindya Roy
Executive officer and director